Which pharmacists contribute to high-level pharmacotherapy audit meetings with general practitioners?

Annals of Pharmacotherapy

Volumn 40, Issue 9, 2006, Pages 1640-1646

  Florentinus, Stefan R ^a   Van Hulten, Rolf ^a   Kramer, Marjolein ^a   Van Dijk, Liset ^b   Heerdink, Eibert R ^a   Leufkens, Hubert G M ^a   Groenewegen, Peter P ^b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Community pharmacy; General practitioner; Pharmacotherapy

Indexed keywords

ARTICLE; COMMUNITY CARE; DECISION MAKING; DRUG CHOICE; DRUG INDUSTRY; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MEDICAL AUDIT; NETHERLANDS; PATIENT CARE; PATIENT COUNSELING; PHARMACIST; PHARMACIST ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE;

COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICAL AUDIT; NETHERLANDS; PHARMACISTS; PHYSICIANS, FAMILY; PRESCRIPTIONS, DRUG; QUESTIONNAIRES;

EID: 33748294309     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H180     Document Type: Article

References (22)

1. Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother 2004;38:764-70. Epub 18 Mar 2004. DOI 10.1345/aph.1D419
2. Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract 2003;53:600-6.
3. Guzman J, Esmail R, Karjalainen K, Malmivaara A, Irvin E, Bombardier C. Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ 2001;322:1511-6.
4. Avery AJ, Pringle M. Extended prescribing by UK nurses and pharmacists. BMJ 2005;331:1154-5.
5. Medicines and Healthcare Products Regulatory Agency (MHRA) DoH. Consultation on proposals to introduce independent prescribing by pharmacists. www.dh.gov.uk/assetRoot/04/10/48/81/04104881.pdf (accessed 14 Nov 2005).
6. van Mil JWF, Schulz M, Tromp TFJD. Pharmaceutical care, European developments in concepts, implementation, teaching, and research: a review. Pharm World Sci 2004;26:303-11.
7. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998;32:636-41. DOI 10.1345/aph.17095
8. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
9. Borenstein JE, Graber G, Saltiel E, et al. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy 2003;23:209-16.
10. Bradley CP, Taylor RJ, Blenkinsopp A. Primary care-opportunities and threats. Developing prescribing in primary care. BMJ 1997;314:744-7.
11. Kocken GA. Medication discussion groups in the Netherlands: five years of experience. Med Educ 1999;33:390-3.
12. Blom AT, Paes AH, Bakker A, Koopman CJ, van der Meer C. Pharmacist-physician co-operation at a regional level. Pharm World Sci 1994; 16:13-7.
13. Van Dijk L, Barnhoorn H, De Bakker DH. [Pharmacotherapy audit meetings in 1999: the state of affairs] Dutch. Utrecht: NIVEL, 2001.
14. DGV. FTO-peiling 2003. [Dutch Institute for Effective Use of Medication]. www.medicijngebruik.nl/coment/17_vind_op_thema/17-7-1.htm (accessed 2005 Aug 10).
15. DGV. FTO-peiling 2004 [Dutch Institute for Effective Use of Medication]. www.dgvinfo.nl/content/5_persberichten/5-4.htm#5 (accessed 2006 Aug 8).
16. Van Dijk L, de Bakker DH. Professionalization of Dutch PRGs and volume and costs of frequently prescribed drugs. Zeitschrift für Gesundheitswissenschaften 2002;10:292-304.
17. De Vries CS. Collaboration in healthcare: the tango to drug safety. Department of Social Pharmacy & Pharmacoepidemiology, University Centre for Pharmacy. Groningen Institute for Drug Studies. Groningen: State University Groningen, 1998.
18. Muijrers PE, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RP. Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist. Pharm World Sci 2003;25:235-41.
19. Westert GP, Schellevis FG, de Bakker DH, Groenewegen PP, Bensing JM, van der Zee J. Monitoring health inequalities through general practice: the Second Dutch National Survey of General Practice. Eur J Public Health 2005;15:59-65.
20. Schwarzer R. Self-efficacy: thought control of action. Washington, DC: Hemisphere, 1992.
21. Storimans MJ, Klungel OH, Talsma H, Bouvy ML, de Blaey CJ. Collaborative services among community pharmacies for patients with diabetes. Ann Pharmacother 2005;39:1647-53. Epub 6 Sept 2005. DOI 10.1345/aph.1G109
22. Pronk MC, Blom LT, Jonkers R, Rogers EM, Bakker A, de Blaey KJ. Patient oriented activities in Dutch community pharmacy: diffusion of innovations. Pharm World SCi 2002;24:154-61.